Literature DB >> 30010402

hsa_circ_0000177-miR-638-FZD7-Wnt Signaling Cascade Contributes to the Malignant Behaviors in Glioma.

Zhiqiang Chen1, Xingbang Duan1.   

Abstract

As a new member of the noncoding RNA family, circular RNAs (circRNAs) have been demonstrated as critical regulators in various physiological and pathological processes, such as tumorigenesis. However, the role of circRNAs has not been well understood until now. In our study, we found that circRNA hsa_circ_0000177 was upregulated in glioma tissues and cell lines. Also, hsa_circ_0000177 overexpression was associated with poor prognosis in glioma patients. Through functional experiments, we found that hsa_circ_0000177 knockdown dramatically inhibited glioma cell proliferation and invasion in vitro. Consistently, hsa_circ_0000177 knockdown significantly repressed glioma growth in vivo. In terms of mechanism, we used bioinformatics analysis and identified hsa_circ_0000177 as a miR-638 sponge. We showed that miR-638 inhibition could restore the proliferation and invasion of glioma cells transfected with hsa_circ_0000177 small interfering RNA. Furthermore, we demonstrated that frizzled class receptor 7 (FZD7) was targeted by miR-638 and upregulated by hsa_circ_0000177. Through upregulating FZD7 expression, hsa_circ_0000177 activated Wnt signaling and facilitated glioma growth. Taken together, our study revealed a novel signaling pathway involved in glioma progression.

Entities:  

Keywords:  circular RNA; glioma; hsa_circ_0000177; invasion; miR-638; proliferation

Mesh:

Substances:

Year:  2018        PMID: 30010402     DOI: 10.1089/dna.2018.4294

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  20 in total

Review 1.  Circular RNAs: Functions and Prospects in Glioma.

Authors:  Zheng Hao; Si Hu; Zheng Liu; Weixin Song; Yeyu Zhao; Meihua Li
Journal:  J Mol Neurosci       Date:  2018-11-20       Impact factor: 3.444

2.  Hsa_circ_0008344 Promotes Glioma Tumor Progression and Angiogenesis Presumably by Regulating miR-638/SZRD1 Pathway.

Authors:  Liyong Deng; Kuiyu Gong; Guihua Wang
Journal:  Neurotox Res       Date:  2022-04-08       Impact factor: 3.911

3.  Circular RNAs and human glioma.

Authors:  Jinglei Liu; Kun Zhao; Nunu Huang; Nu Zhang
Journal:  Cancer Biol Med       Date:  2019-02       Impact factor: 4.248

4.  FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma.

Authors:  Zhenwei He; Xuelei Ruan; Xiaobai Liu; Jian Zheng; Yunhui Liu; Libo Liu; Jun Ma; Lianqi Shao; Di Wang; Shuyuan Shen; Chunqing Yang; Yixue Xue
Journal:  J Exp Clin Cancer Res       Date:  2019-02-08

5.  miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.

Authors:  Qiang Liu; Yanlei Guan; Zhenhang Li; Yao Wang; Yu Liu; Run Cui; Yunjie Wang
Journal:  J Exp Clin Cancer Res       Date:  2019-08-16

6.  Progress of research into circular RNAs in urinary neoplasms.

Authors:  Bangbei Wan; Bo Liu; Cai Lv
Journal:  PeerJ       Date:  2020-02-24       Impact factor: 2.984

Review 7.  Circular RNAs Regulate Cancer Onset and Progression via Wnt/β-Catenin Signaling Pathway.

Authors:  Yun Feng Li; Jian Zhang; Lei Yu
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

8.  A novel circular RNA circENTPD7 contributes to glioblastoma progression by targeting ROS1.

Authors:  Fei Zhu; Cheng Cheng; Hong Qin; Hongsheng Wang; Hailong Yu
Journal:  Cancer Cell Int       Date:  2020-04-10       Impact factor: 5.722

9.  Extracellular vesicle-mediated crosstalk between NPCE cells and TM cells result in modulation of Wnt signalling pathway and ECM remodelling.

Authors:  Natalie Lerner; Sofia Schreiber-Avissar; Elie Beit-Yannai
Journal:  J Cell Mol Med       Date:  2020-03-13       Impact factor: 5.310

Review 10.  Functional roles of circular RNAs during epithelial-to-mesenchymal transition.

Authors:  Bing-Qing Shang; Min-Le Li; Hao-Yu Quan; Ping-Fu Hou; Zhong-Wei Li; Su-Fang Chu; Jun-Nian Zheng; Jin Bai
Journal:  Mol Cancer       Date:  2019-09-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.